Literature DB >> 6262285

beta-Endorphin central depression of respiration and circulation.

I R Moss, E M Scarpelli.   

Abstract

Beta-Endorphin was injected into cerebrospinal fluid of lightly anesthetized dogs. Its effects on ventilation (V), tidal volume (VT), respiratory frequency (f), preinspiratory occlusion pressure (P500), and respiratory timing of unoccluded and occluded breaths were studied during CO2 rebreathing. Blood pressure and heart rate (HR) were monitored throughout the study. beta-Endorphin produced 1) early (approximately 15 min) but temporary depression of VT-PCO2 and P500-PCO2 responses; 2) progressive hypoventilation during spontaneous breathing and progressive depression of V-PCO2 and f-PCO2 responses, which were maximal at about 75 min, followed by gradual recovery; 3) progressive hypotension and bradycardia starting at about 15 min and reaching maximal effect at about 105 min. Increased expiratory time (TE) accounted for the changes in f. TE increased in unoccluded breaths and during both preinspiratory and inflation occlusion. After vagotomy, beta-endorphin produced insignificant effect on f, TE, and HR. Naloxone itself increased P500-PCO2 response; when given during beta-endorphin effect, it reversed the hypotension, bradycardia, V-PCO2, and f-PCO2 responses and facilitated the P500-PCO2 and VT-PCO2 responses. We conclude that beta-endorphin effect is produced by both depression of specific central cardiovascular and respiratory control units and facilitation of central vagal projections.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262285     DOI: 10.1152/jappl.1981.50.5.1011

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  8 in total

Review 1.  Opioids and exercise. An update.

Authors:  G A Sforzo
Journal:  Sports Med       Date:  1989-02       Impact factor: 11.136

2.  Endorphins and the neonate.

Authors:  K W Hindmarsh; K Sankaran
Journal:  Can Med Assoc J       Date:  1985-02-15       Impact factor: 8.262

Review 3.  Naloxone: new therapeutic roles.

Authors:  B Milne; K Jhamandas
Journal:  Can Anaesth Soc J       Date:  1984-05

4.  Effects of naloxone on apnoea duration during sleep in infants at risk for SIDS.

Authors:  R Haidmayer; R Kerbl; U Meyer; P Kerschhaggl; R Kurz; T Kenner
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

5.  Some species differences in cardiovascular responses to intravenously injected leucine-enkephalin.

Authors:  S Koyama; N Terada; Y Shiojima; T Takeuchi
Journal:  Experientia       Date:  1985-11-15

6.  Naloxone and the ventilatory response to exercise in man.

Authors:  C Griffis; R D Kaufman; S A Ward
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

7.  Endogenous opiates and the control of breathing in normal subjects and patients with chronic airflow obstruction.

Authors:  M V Tabona; N Ambrosino; P J Barnes
Journal:  Thorax       Date:  1982-11       Impact factor: 9.139

8.  The effects of opiates on the respiratory activity of thoracic motoneurones in the anaesthetized and decerebrate rabbit.

Authors:  R S Howard; T A Sears
Journal:  J Physiol       Date:  1991-06       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.